2015

/Tag:2015

Oramed to Raise $5.36 Million in Registered Direct Offering

JERUSALEM, June 5, 2015 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (https://www.oramed.com), a developer of oral drug delivery systems, today announced that it entered into purchase agreements with several institutional investors for a registered direct placement. The Stock Purchase Agreements provide for the sale of [...]

2018-05-30T17:04:20+00:00 Categories: Press Releases|Tags: |

Oramed to Present at the American Diabetes Association 75th Scientific Sessions

JERUSALEM, June 2, 2015 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that a scientific abstract summarizing studies performed with ORMD-0801, its orally ingestible insulin capsule on type 1 diabetic [...]

2018-05-30T17:04:21+00:00 Categories: Press Releases|Tags: |

Oramed to Present at Upcoming Conferences

Presentations Scheduled at Oppenheimer 16th Annual Israeli Conference and IATI Biomed 2015 in May JERUSALEM, May 5, 2015 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the company will [...]

2018-05-30T17:04:21+00:00 Categories: Press Releases|Tags: |

Oramed to Present at the GTC Diabetes Summit

Company to present on April 28, 2015 JERUSALEM, April 20, 2015 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the company will participate in the upcoming Annual GTC Diabetes [...]

2018-05-30T17:04:22+00:00 Categories: Press Releases|Tags: |

Oramed to Present at the ROTH Conference

On March 10, 2015 JERUSALEM, March 4, 2015 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the company will participate in the upcoming 27th Annual ROTH Conference, taking place [...]

2018-05-30T17:04:23+00:00 Categories: Press Releases|Tags: |

Oramed to Present Poster at the GTC Protease Inhibitors in Drug Discovery Conference

JERUSALEM, February 19, 2015 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that a scientific abstract titled "Protease Inhibitor Support in Oral Insulin Delivery" will be presented in poster sessions [...]

2018-05-30T17:04:23+00:00 Categories: Press Releases|Tags: |